- Home
- MEC vs ALDX Comparison
MEC vs ALDX Comparison
Compare MEC & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEC
- ALDX
- Stock Information
- Founded
- MEC 1945
- ALDX 2004
- Country
- MEC United States
- ALDX United States
- Employees
- MEC N/A
- ALDX 9
- Industry
- MEC Industrial Specialties
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- MEC Industrials
- ALDX Health Care
- Exchange
- MEC Nasdaq
- ALDX Nasdaq
- Market Cap
- MEC 324.5M
- ALDX 398.3M
- IPO Year
- MEC 2019
- ALDX 2014
- Fundamental
- Price
- MEC $13.49
- ALDX $6.67
- Analyst Decision
- MEC Strong Buy
- ALDX Strong Buy
- Analyst Count
- MEC 3
- ALDX 2
- Target Price
- MEC $20.67
- ALDX $10.00
- AVG Volume (30 Days)
- MEC 139.6K
- ALDX 767.7K
- Earning Date
- MEC 03-04-2025
- ALDX 05-01-2025
- Dividend Yield
- MEC N/A
- ALDX N/A
- EPS Growth
- MEC 226.32
- ALDX N/A
- EPS
- MEC 1.24
- ALDX N/A
- Revenue
- MEC $581,604,000.00
- ALDX N/A
- Revenue This Year
- MEC $4.91
- ALDX N/A
- Revenue Next Year
- MEC $1.59
- ALDX N/A
- P/E Ratio
- MEC $10.91
- ALDX N/A
- Revenue Growth
- MEC N/A
- ALDX N/A
- 52 Week Low
- MEC $12.75
- ALDX $3.10
- 52 Week High
- MEC $23.02
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- MEC 34.42
- ALDX 54.67
- Support Level
- MEC $13.73
- ALDX $6.30
- Resistance Level
- MEC $14.07
- ALDX $6.81
- Average True Range (ATR)
- MEC 0.46
- ALDX 0.44
- MACD
- MEC -0.01
- ALDX -0.05
- Stochastic Oscillator
- MEC 3.05
- ALDX 49.52
About MEC Mayville Engineering Company Inc.
Mayville Engineering Co Inc is involved in a manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.